Heather M. Wilson
1.University of Aberdeen
Institute of Medical Sciences
Foresterhill
Aberdeen
UK
Name/email consistency: high
- Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. Whyte, C.S., Bishop, E.T., Rückerl, D., Gaspar-Pereira, S., Barker, R.N., Allen, J.E., Rees, A.J., Wilson, H.M. J. Leukoc. Biol. (2011)
- Macrophages heterogeneity in atherosclerosis - implications for therapy. Wilson, H.M. J. Cell. Mol. Med. (2010)
- Macrophages: promising targets for the treatment of atherosclerosis. Wilson, H.M., Barker, R.N., Erwig, L.P. Curr. Vasc. Pharmacol (2009)
- Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Wilson, H.M., Chettibi, S., Jobin, C., Walbaum, D., Rees, A.J., Kluth, D.C. Am. J. Pathol. (2005)
- Macrophages and the kidney. Wilson, H.M., Walbaum, D., Rees, A.J. Curr. Opin. Nephrol. Hypertens. (2004)
- Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Wilson, H.M., Stewart, K.N., Brown, P.A., Anegon, I., Chettibi, S., Rees, A.J., Kluth, D.C. Mol. Ther. (2002)
- Transforming growth factor-beta isoforms and glomerular injury in nephrotoxic nephritis. Wilson, H.M., Minto, A.W., Brown, P.A., Erwig, L.P., Rees, A.J. Kidney Int. (2000)
- Opposing effects of interleukin-1 and transforming growth factor-beta on the regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 expression by human mesangial cells. Wilson, H.M., Haites, N.E., Booth, N.A. Exp. Nephrol. (1997)
- Effect of angiotensin II on plasminogen activator inhibitor-1 production by cultured human mesangial cells. Wilson, H.M., Haites, N.E., Booth, N.A. Nephron (1997)